Venus Remedies Limited (BOM:526953)
1,670.10
+43.55 (2.68%)
At close: Sep 25, 2026
Venus Remedies Market Cap
Venus Remedies has a market cap or net worth of 22.32 billion as of September 25, 2026. Its market cap has increased by 273.37% in one year.
Market Cap
22.32B
Enterprise Value
21.41B
Revenue
8.11B
Ranking
n/a
PE Ratio
19.22
Stock Price
1,670.10
ChartMarket Cap Chart
Since October 19, 2004, Venus Remedies's market cap has increased from 242.83M to 22.32B, an increase of 9,093.24%. That is a compound annual growth rate of 22.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 22.32B | 117.74% |
| Dec 31, 2025 | 10.25B | 139.58% |
| Dec 31, 2024 | 4.28B | -21.14% |
| Dec 29, 2023 | 5.43B | 124.10% |
| Dec 30, 2022 | 2.42B | -55.77% |
| Dec 31, 2021 | 5.48B | 194.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Unichem Laboratories | 38.74B |
| Kwality Pharmaceuticals | 38.10B |
| Hikal | 26.87B |
| Shukra Pharmaceuticals | 24.50B |
| Fredun Pharmaceuticals | 22.51B |
| Syncom Formulations (India) | 18.86B |
| Amrutanjan Health Care | 14.63B |
| TTK Healthcare | 14.57B |